BioHeart – A-14 Heart

BioHeart – A-14 Heart (also known as Chelohart) is a natural peptide bioregulator dietary supplement formulated with cardiac muscle peptides. It is designed to support myocardial cell metabolism, heart function, and healthy aging of cardiac tissue as part of the Khavinson Cytomax line of tissue-specific peptide complexes.

What Is BioHeart – A-14 Heart Peptide Bioregulator (Chelohart)?

BioHeart A-14 contains natural peptide fractions extracted from the heart muscle of young animals (typically calves). These short-chain peptides belong to the Cytomax family of natural bioregulators developed from research at the St. Petersburg Institute of Bioregulation and Gerontology led by Professor Vladimir Khavinson.

Unlike broad cardiovascular supplements, BioHeart is tissue-specific. It targets cardiomyocytes (heart muscle cells) to help normalize metabolism and support protein synthesis that can decline with age. It is positioned as a natural geroprotector with extended action.

Each capsule typically provides 40 mg (0.04 g) of Peptide complex A-14 (heart peptides), with other ingredients including microcrystalline cellulose, calcium stearate, and a hydroxypropyl methylcellulose (vegetarian) capsule. It is gluten-free and non-GMO. Available in 20-capsule (approx. 10-day) or 60-capsule (approx. 30-day) packs.

How BioHeart A-14 Works

According to the bioregulator model, short peptides interact with chromatin in target cells and help modulate gene expression related to cardiac muscle function, energy metabolism, and cellular maintenance. This may support:

• Restoration of protein synthesis in myocardial cells
• Normalization of metabolism in cardiac tissue
• Maintenance of cardiomyocyte functional activity

Heart muscle cells have limited regenerative capacity and rely heavily on efficient protein turnover and mitochondrial energy production. Age-related slowdowns in these processes can affect overall cardiac efficiency. BioHeart is intended to supply tissue-specific peptide signals that support these cellular processes.

Potential Benefits of BioHeart A-14 Heart Peptide Bioregulator

Product literature and related research on Khavinson cardiac peptides highlight support in these areas (these statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease):

• Regulation and support of heart function
• Normalization of metabolism in cardiac muscle cells
• Help inhibiting age-related atrophic processes in the myocardium
• Maintenance of myocardial functional activity, particularly relevant with advancing age
• Support during recovery periods (e.g., post-myocardial infarction context in research framing)
• Assistance with cardiovascular wellness in the context of ischemic concerns or hypertension (as complementary support)
• Relevance for individuals under increased physical demands

Who May Consider BioHeart A-14?

BioHeart is commonly positioned for adults interested in proactive cardiovascular and longevity support, including those focused on:

• Age-related maintenance of heart muscle function
• Supporting recovery and resilience after physical stress
• Complementary approaches alongside lifestyle measures for cardiovascular wellness
• Research or personal protocols involving peptide bioregulators

It is not a substitute for medical care, prescribed medications, or lifestyle interventions (diet, exercise, stress management, and regular check-ups).

Contraindications typically listed: individual sensitivity to components, pregnancy, and breastfeeding. Consult a healthcare professional before use, especially if you have diagnosed heart conditions or take medications.

Suggested Use and Dosage

Common suggested use from product information:

• Adults: 1–2 capsules, 1–2 times daily with food
• Typical course: 10–30 days (20 or 60 capsules)
• Store in a dry, dark place at +2°C to +25°C
• Shelf life: approximately 3 years from production

Scientific Background

BioHeart A-14 draws from decades of research on tissue-specific peptide bioregulators. Khavinson’s work has explored how short peptides can influence gene expression and cellular function in a tissue-selective manner. Broader studies on peptide bioregulator complexes have examined effects on aging markers, organ function, and longevity parameters in both experimental and clinical settings. Cardiac-specific applications focus on cardiomyocyte biology and myocardial metabolism.

Frequently Asked Questions

Is BioHeart the same as Chelohart? Yes. BioHeart is the branding used for the A-14 Heart Peptide Bioregulator, also known as Chelohart.

How does it differ from synthetic cardiac peptides? BioHeart is a natural Cytomax complex containing multiple short peptides from tissue extract. Synthetic versions (Cytogens) are single sequenced peptides that may act more rapidly but with a narrower range.

Can it be combined with other supplements? It is frequently discussed in combination with vessel-targeted bioregulators (e.g., Ventfort) and other Cytomaxes. Always check with a healthcare provider for interactions.

Is it FDA-approved? No. It is sold as a dietary supplement. Claims have not been evaluated by the FDA.